Menu
Montecito
PacPremier
Loading...
You are here:  Home  >  'biotechnology'  -  Page 2
Latest

MannKind makes $12.5M pharma buy

By   /  Monday, December 7th, 2020  /  Banking & Finance, Biotech, East Ventura County, Latest news, Technology, Tri-County Economy, Tri-County Public Companies  /  Comments Off on MannKind makes $12.5M pharma buy

MannKind Corp., a biotech company based in Westlake Village, announced Dec. 7 that it has acquired a QrumPharma, a privately held biotech company, in a $12.5 million deal. MannKind has purchased all outstanding capital stock of QrumPharma for $3.5 million in cash and just over 3 million shares of MannKind common stock. At MannKind’s stock Read More →

Read More →
Latest

Tri-county stocks reverse prior day’s losses, gain 9.3 percent

By   /  Friday, March 13th, 2020  /  Agribusiness, Banking & Finance, Banking Industry, Biotech, Latest news, Tri-County Economy, Tri-County Public Companies  /  Comments Off on Tri-county stocks reverse prior day’s losses, gain 9.3 percent

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Arcutis planning $152 million IPO

By   /  Tuesday, January 28th, 2020  /  Biotech, Latest news  /  Comments Off on Arcutis planning $152 million IPO

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

MannKind burns through $23.3 million in cash

By   /  Tuesday, November 7th, 2017  /  Central Coast Health Watch, Earnings, Latest news, Technology, Tri-County Public Companies  /  Comments Off on MannKind burns through $23.3 million in cash

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Sienna stock soars after $65 million IPO

By   /  Thursday, July 27th, 2017  /  Central Coast Health Watch, Earnings, East Ventura County, Latest news, Tri-County Public Companies  /  Comments Off on Sienna stock soars after $65 million IPO

Westlake Village biotechnology company Sienna Biopharmaceuticals closed with a big gain after it raised $65 million in its initial public offering July 27. Sienna priced the 4.33 million shares it offered at $15. Shares had reached $21 around noon before ending at $19.25, a 28.3 percent premium on its opening price. The company operates in Read More →

Read More →
Latest

Sienna Biopharmaceuticals files for $75 million IPO

By   /  Thursday, July 6th, 2017  /  Central Coast Health Watch, East Ventura County, Latest news, Technology, Tri-County Public Companies  /  Comments Off on Sienna Biopharmaceuticals files for $75 million IPO

Westlake Village biotechnology company Sienna Biopharmaceuticals filed for an initial public offering with the Securities and Exchange Commission on June 3, stating expectations to raise up to $74.75 million. Founded in 2010, the company develops clinical-stage topical therapies for inflammatory skin diseases and other conditions. ARCH Venture Partners and Venvest Capital led a $40 million Read More →

Read More →
Latest

MannKind hires financial adviser after boosting cash on hand

By   /  Thursday, June 29th, 2017  /  Central Coast Health Watch, East Ventura County, Latest news, Technology, Tri-County Public Companies  /  Comments Off on MannKind hires financial adviser after boosting cash on hand

MannKind, a Southern California biotechnology company heading to Westlake Village, hired Greenhill & Co. as a financial and strategic adviser June 28, after requesting the last of its line of credit through a loan from the Mann Group. The company will draw on the remaining $30.1 million of funding, using $10.6 million to capitalize unpaid Read More →

Read More →